Comparison between biosimilar filgrastim vs other granulocyte-colony stimulating factor formulations (originator filgrastim, peg-filgrastim and lenograstim) after autologous stem cell transplantation: a retrospective survey from the Rome Transplant Network

Br J Haematol. 2015 Apr;169(2):293-6. doi: 10.1111/bjh.13199. Epub 2014 Nov 5.

Authors

Francesco Marchesi¹, Elisabetta Cerchiara, Maria Laura Dessanti, Svitlana Gumenyuk, Luca Franceschini, Francesca Palombi, Francesco Pisani, Atelda Romano, Antonio Spadea, Livio Pupo, Ombretta Annibali, Antonella La Malfa, William Arcese, Andrea Mengarelli

Affiliation

¹ Haematology and Stem Cell Transplantation Unit, Regina Elena National Cancer Institute, Rome, Italy. marchesi.francesco@tiscali.it.

PMID: 25371286
DOI: 10.1111/bjh.13199

No abstract available

Keywords: growth factors; stem cell mobilization/homing; stem cell transplantation.

Publication types

Letter

MeSH terms

Biosimilar Pharmaceuticals / administration & dosage
Biosimilar Pharmaceuticals / chemistry
Biosimilar Pharmaceuticals / therapeutic use*
Chemistry, Pharmaceutical
Filgrastim
Granulocyte Colony-Stimulating Factor / administration & dosage
Granulocyte Colony-Stimulating Factor / chemistry
Granulocyte Colony-Stimulating Factor / therapeutic use*
Hematologic Neoplasms / therapy
Hematopoietic Stem Cell Transplantation*
Humans
Italy
Recombinant Proteins / administration & dosage
Recombinant Proteins / chemistry
Recombinant Proteins / therapeutic use
Retrospective Studies
Transplantation, Autologous

Substances

Biosimilar Pharmaceuticals
Recombinant Proteins
Granulocyte Colony-Stimulating Factor
Filgrastim